🔎 Trials Near Me

መነሻ › ትሪፕል-ኔጌቲቭ የደረት ካንሰር › ካሊፎርኒያ › Los Angeles

በLos Angeles፣ CA ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ 27 ጥናቶች በLos Angeles እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California - Los Angeles, Los Angeles
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06586957

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UCLA Department of Medicine - Hematology & Oncology ( Site 0047), Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06841354

Intratumoral N17350 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • The Angeles Clinic and Research Institute, Los Angeles
  • UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07339176

Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Ellison Institute of Technology (EITM), Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06353997

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Cedars-Sinai Cancer at Beverly Hills, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT05633654

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • USC/Norris Comprehensive Cancer Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT04895709

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • USC Norris Comprehensive Cancer Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT05985655

SMP-3124LP in Adults With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Cedars Sinai Medical Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT06526819

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT06926868

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Cedars-Sinai Medical Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT05318469

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of California Los Angeles Medical Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT05579366

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Cedars-Sinai Medical Center, Los Angeles
  • Cedars-Sinai Medical Center Beverly Hills, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT07017673

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California LA, Los Angeles
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁላይ 2026 · NCT06562192

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT05005403

Study of XB010 in Subjects With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UCLA Department of Medicine - Hematology/Oncology, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT06545331

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Start Lacn, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT07517198

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • USC / Norris Comprehensive Cancer Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ19 ሜይ 2026 · NCT05989828

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Southern California, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT01042379

Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Cedars-Sinai Medical Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ20 ኤፕሪ 2026 · NCT05491226

Access to Genetic Testing in Underserved Patients With Cancer

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • USC / Norris Comprehensive Cancer Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ማርች 2026 · NCT06422455

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Los Angeles Cancer Network (LACN) - Good Sam, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጃንዩ 2026 · NCT06926920

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Southern California, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኖቬም 2025 · NCT05902988

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UCLA Medical Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2025 · NCT06682793

A Study of NX-1607 in Adults With Advanced Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Southern California, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2025 · NCT05107674

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Valkyrie Clinical Trials, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ጁን 2025 · NCT06568692

በሌሎች ከተሞች ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ጥናቶች

በLos Angeles ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።